Skip to main content
. 2024 Aug 21;12:1398803. doi: 10.3389/fpubh.2024.1398803

Figure 3.

Figure 3

Percentage of NF1 pediatric patients reported problems in different dimensions of EQ-5D-Y by age group. EQ-5D-Y was only for NF1 pediatric patients aged between 4 and 18 (n = 154). NF1, neurofibromatosis type 1.